PHARMACEUTICAL TECHNOLOGY AND NANOTECHNOLOGY
ANALYTICAL AND QUALITY CONTROL METHODS
As a result of the studies was shown that the relative ratios of isomers by integration in DMSO-d6: (S, R)-warfarin – (S, S)-warfarin – open chain warfarin are 70%: 28%: 2%; in СDCl3 are 45%: 40%: 15%. In the IR spectra of warfarin specific absorption bands are observed in the regions 3271–3277 cm-1, 1681–1682 cm-1, 1103–1076 cm-1, corresponding to:νOH, νCH=CH: νas C–O–C. The molecular peak of warfarin after silylation has m/z 380 corresponding to the mass of trimethylsilyl-warfarin. Thus, the possibility of using IR, NMR spectroscopy and chromatography-mass spectrometry to confirm the authenticity of warfarin derivatives has been demonstrated.
DRUG PRODUCTS EFFICACY AND SAFETY
This article shows the results of a study of pharmaceutical equivalence of atorvastatin generics using Dissolution test. A significant difference in the intensity of atorvastatin release from tablets from different manufacturers has been established. From 10 to 97% of atorvastatin was released from tablets of different manufacturers by the 15th minute of the test. In the similitude of the dissolution profiles, 6 generics out of 13 studied were pharmaceutically equivalent to the reference drug in doses 10 mg and 20 mg. It is shown that the inclusion of disintegrants and solubilizers in the formulation leads to an increase in the release rate of the active pharmaceutical substance from the dosage form.
REGULATORY ISSUES
ISSN 2658-5049 (Online)